Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Med Arch. 2022; 76(5): 354-362


The COVID-19 Vaccine Opinions of Women Planning a Pregnancy: International Web Blogs Scanning

Idriz Sopjani, Esra Arbag, Merlinda Alus Tokat, Sevcan Ozozturk.




Abstract

Background: The unprecedented COVID-19 has infected millions of people and killed hundreds of thousands of people. A strategy to contain the spread of the disease was the development of the COVID-19 vaccine. Objective: In our study, it was determined the opinions of women who are planning to become pregnant about the COVID-19 vaccine. Methods: Blogs were used as the data source in the research, which was designed as a descriptive qualitative study. For this purpose, the expressions of 34 women identified between February and March 2021 were evaluated with directed qualitative content analysis. Results: Psychological changes, cognitive changes, and coping methods were determined as the themes of our results. This study demonstrates the value of using qualitative methods to determine the thoughts of women planning to become pregnant regarding the COVID-19 vaccine. Conclusion: For women planning pregnancy, continued research into vaccine safety and efficacy is vital, and results should be carefully investigated and handed in the right channels.

Key words: Blogs, COVID-19, Pregnancy, Pregnancy planning, Vaccine.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.